Christopher A. Email & Phone Number

Sunnyvale, California, US

• Therapeutic areas: immuno-oncology
• Phases: 1-2
• DP candidates: 23ME-00610, 23ME-01473

Redwood City, California, US

• Outsourcing principal responsible for CRO, vendor and site contract oversight in support of then active clinical programs: $200MM annual spend Therapeutic areas: oncology
• Phases: 1-3
• DP candidates: RMC-4630, RMC-5552, RMC-6236, RMC-6291, and RMC-9805

South San Francisco, CA, US

• ClinOps business partner responsible for outsourced services across then active clinical programs, including budget review and negotiation with CROs, investigational sites and other vendors: $120MM annual spend.
• Phases: 1-3
• DP candidates: NGM120, NGM438, NGM707, NGM831 and Aldafermin (NGM282)

Lawrence Township, NJ, US

• Post-merger integration from MyoKardia’s Development Outsourcing into BMS’ DevOps: Global Clinical Trial Planning & Alliance Management Therapeutic area: cardiovascular
• Phases: 1-3
• DP candidates: mavacamten (MYK-461), danicamtiv (MYK-491) and MYK-224

Brisbane, California, US

• Outsourcing consultant (c/o Advanced Clinical) on assignment with MyoKardia, Inc. (acq. by Bristol Myers Squibb) responsible for site budget and contract life cycle management for then active clinical programs.
• Phases: 1-3
• DP candidates: mavacamten (MYK-461), danicamtiv (MYK-491) and MYK-224 MyoKardia, acquired by Bristol Myers Squibb in Nov 2020, was then a clinical-stage biopharmaceutical company discovering and developing targeted.

San Francisco, California, US

• Team Lead and Interim Associate Director responsible for managing daily operations and the workflow of MCA and Study Ops teams, to maximize throughput and billing compliance for 1,500+ clinical trials performed across.
• Phases: 0-4

Los Angeles, CA, US

Los Angeles, CA, US

• PM responsible to improve efficiency of the clinical trial activation process for studies conducted within the USC Keck enterprise and at the LAC+USC Medical Center Therapeutic areas: oncology, hematology, surgery.
• Phases: 1-3

Los Angeles, CA, US

• Business Manager of the $109MM NIH-funded AIDS Malignancy Consortium (AMC, amcoperations.com) responsible for administrative, operational and fiscal management across 14 clinical trials at 36 domestic and 8.
• Phases: 1-2 The AMC was established in 1995 with the overarching goal to develop innovative and effective strategies for prevention and treatment of cancers in people living with HIV. It is the only cooperative.

Los Angeles, CA, US

• Sr. Fund Manager in the Jonsson Comprehensive Cancer Center responsible for oversight of all aspects of pre- and post-award administration related to industry-sponsored clinical trial contracts: cumulative $15M A/R.
• Phases: 1-3

Denver, CO, US

Denver, CO, US

Supported Berkeley, San Leandro-Bayfair, San Francisco-Chinatown, San Rafael-Northgate and Daly City-Westlake clinics

Nursing

High School Diploma, Christian Studies